Advantages of dapsone over trimethoprim/sulfamethoxazole for Pneumocystis pneumonia prophylaxis in patients with immunobullous disease

J Am Acad Dermatol. 2021 Dec;85(6):e325. doi: 10.1016/j.jaad.2019.01.091. Epub 2019 Feb 27.

Authors

Spyros M Siscos¹, Brett C Neill¹, Isadore S Tarantino¹, Daniel J Aires¹, Anand Rajpara²

Affiliations

¹ Division of Dermatology, University of Kansas Medical Center, Kansas City, Kansas.
² Division of Dermatology, University of Kansas Medical Center, Kansas City, Kansas. Electronic address: arajpara@kumc.edu.

PMID: 30825531
DOI: 10.1016/j.jaad.2019.01.091

No abstract available

Keywords: bullous pemphigoid; dapsone; pemphigus vulgaris; pneumocystis.

MeSH terms

Dapsone* / therapeutic use
Humans
Pneumonia, Pneumocystis* / prevention & control
Skin Diseases
Trimethoprim, Sulfamethoxazole Drug Combination* / therapeutic use

Substances

Trimethoprim, Sulfamethoxazole Drug Combination
Dapsone